跳至主要内容
临床试验/NCT03204305
NCT03204305已完成早期 1 期

Brain Imaging of Cannabinoid Receptors in Women

Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2017年9月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
28
试验地点
1
主要终点
Distribution Volume (VT)

研究概览

简要总结

All participants will be healthy volunteers and all procedures will be completed for research purposes only. Two groups will be recruited, females who use cannabis (marijuana, MJ), and female who do not use cannabis (controls). Female MJ users will be enrolled in a protocol that includes an outpatient drug administration session and a 4-day/3-night inpatient stay on the Johns Hopkins Bayview Clinical Research Unit (CRU). During outpatient visits, MJ users will have an MRI, and complete MJ self-administration and cognitive performance sessions. MJ users will then reside on the CRU,and complete MJ abstinence, and self-report instruments for withdrawal discomfort. A positron emission tomography (PET) scan of brain cannabinoid type 1 receptors will also be completed. Non-users will complete MRI, PET imaging and cognitive testing under an outpatient protocol (no MJ administration).

详细描述

The primary goals of this project are to examine whether use of cannabis alters brain cannabinoid type 1 receptor (CB1R) availability in females, and if severity of cannabis withdrawal is correlated with CB1 receptor availability. CB1R are widely distributed in the human brain and can be quantified using PET imaging with the radiotracer 11C-OMAR (Carbon-11-OMAR). The effects MJ use on brain CB1R have not been studied in females. The current study will enroll 10 female MJ users in an inpatient protocol that includes administration of smoked MJ, followed by monitored abstinence with daily behavioral assessments, and PET imaging with 11C-OMAR. PET data will collected in 10 matched controls for comparison. The proposed study is an important first step to determine whether localized CB1R changes in female MJ users help explain, and provide a neurobiological target for intervention. Results will increase knowledge of cannabinoid mechanisms of cannabis use and severity of dependence in females, an understudied population.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

盲法说明

Cannabis THC content (dose) is masked for participant

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • < 5th grade reading level
  • Current Diagnostic and Statistical Manual, version 5 (DSM-5) psychiatric disorder;
  • Current DSM-5 alcohol or substance use disorder (excluding MJ or nicotine)
  • Recent Illicit drug use or positive drug test
  • Using MJ under the guidance of MD;
  • History of seizures, closed head trauma;
  • unstable hypertension;
  • conditions preventing magnetic resonance imaging (MRI) such as implanted metal, claustrophobia, or anatomical abnormalities (e.g., enlarged ventricles, brain lesions);
  • Use of medications or herbal supplements which may be counter indicated as determined by study physician
  • Have had exposure to ionizing radiation that in combination with the study's estimated radiation exposure would result in a cumulative exposure that exceeds recommended exposure limits of 5 rem per year.
  • Presence or history of drug allergy, or allergic disease diagnosed and treated by a physician.
  • any serious medical condition in whom participation is contraindicated.

研究组 & 干预措施

Cannabis users

Active Comparator

Smoked Cannabis plant material (0 and 25 mg THC) will be administered to volunteers who are regular cannabis users. Cannabis users will also complete a PET scan where 20 millicurie of 11C-OMAR

干预措施: 11C-OMAR (Drug)

Cannabis users

Active Comparator

Smoked Cannabis plant material (0 and 25 mg THC) will be administered to volunteers who are regular cannabis users. Cannabis users will also complete a PET scan where 20 millicurie of 11C-OMAR

干预措施: Cannabis (Drug)

Nonuser controls

Active Comparator

No cannabis administration. Non-user controls will complete a PET scan where 20 millicuries of 11C-OMAR

干预措施: 11C-OMAR (Drug)

结局指标

主要结局

Distribution Volume (VT)

时间窗: Collected during 90-min PET study

Distribution Volume (VT) is the quantification of 11C-OMAR binding to the CB1R; Per our statistical plan we examined VT for eight volumes of interest in the brain (ventral striatum, amygdala, putamen, cingulate, globus pallidus, insula, frontal cortex, and hippocampus) as well as the composite VT for the brain. The unit of measure is mL/cm\^3.

次要结局

  • Peak Change From Baseline Marijuana Withdrawal Discomfort Score(Up to 5 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验